ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

House Passes 2.8 Percent Increase For NCI

December 11, 2009

Anil Potti Explains: “Coming from India, I Did Not Know This Was Not The Real Rhodes Scholarship”

December 16, 2011

NCI Still Supporting Construction Grants Despite Big Cuts

February 20, 1981

CIS Cost Sharing Feasibility Study Recommended

December 11, 1987

AZT Trial Unblended, Controls Get Drugs; Gallo, Essex Win Lasker With Montagnier

September 26, 1986

ASCO Supports Tobacco Tax Increase

March 7, 2003